Rapid Micro Biosystems, Inc. (NasdaqCM: RPID)
Health Care · Life Sciences Tools & Services · US
$0.87
-3.12% today · -72.2% 1Y
Rapid Micro Biosystems, Inc. (NasdaqCM: RPID) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $44.82M and employs 171 people.
Over the last twelve months the share price has lost 72.2%, trading between 0.83 and 4.94.
Tweenvest scores Rapid Micro Biosystems, Inc. across four factors: quality 43/100, value 64/100, growth 94/100. Its strongest factor is growth.
RPID price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.82M
- Revenue (TTM)
- $35.18M
- P/E
- —
- EPS
- -1.11
- Dividend yield
- —
- Beta (5Y)
- 1.51
- 52-week high
- $4.94
- 52-week low
- $0.83
- Avg volume (3M)
- —
- Shares outstanding
- 50.16M
- Employees
- 171
- Next earnings
- —
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutions for identifying microbial impurities in the production processes of pharmaceuticals, medical devices, and personal care goods across North America, Europe, and Asia. Central to their offerings is the Growth Direct platform, a comprehensive system comprising the Growth Direct instrument, specialized disposable components, software for seamless integration with laboratory information management systems (LIMS), and extensive customer validation and support services. This innovative platform is designed to automate and modernize traditional, labor-intensive microbial quality control (MQC) testing workflows, which are critical for diverse therapeutic modalities such as biologics, vaccines, cutting-edge cell and gene therapies, and sterile injectable medications. Beyond their core product, the company also delivers essential services, including system installation, verification, expert technical training, and continuous support. Their technologies are widely applied in vital areas like environmental monitoring, water quality testing, bioburden assessment, and final sterility release evaluations. Established in 2006, the company initially traded as Genomic Profiling Systems, Inc., before rebranding to Rapid Micro Biosystems, Inc. in January 2007, and maintains its headquarters in Lowell, Massachusetts.
- ISIN
- US75340L1044
- Founded
- 2006
- Listed since
- Jul 15, 2021
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Carna Biosciences, Inc.TSE: 4572 | $49.53M | ¥368.00 | -10.90% |
| ENCell Co., Ltd.KOSDAQ: A456070 | $48.16M | ₩5,870.00 | -2.17% |
| Chiome Bioscience Inc.TSE: 4583 | $46.85M | ¥94.00 | -7.84% |
| Austar Lifesciences LimitedSEHK: 6118 | $45.72M | HK$0.70 | -2.78% |
| Abnova (Taiwan) CorporationTWSE: 4133 | $42.89M | NT$22.65 | +10.76% |
| Eone Diagnomics Genome Center Co., Ltd.KOSDAQ: A245620 | $42.41M | ₩— | — |
| Macter International LimitedKASE: MACTER | $41.22M | PKRs249.15 | -1.90% |
| MEDINET Co., Ltd.TSE: 2370 | $41.20M | ¥23.00 | -4.17% |
Figures last refreshed Oct 11, 2026.